How can you Improve Efficiencies in your Long-Range Planning?
No element of pharmaceutical forecasting is easy but there’s a particular challenge in long-range planning. The range of components involved results in a greater degree of complexity which can allow inaccuracies to creep in very easily. We covered some of the key challenges in a recent webinar, The Forecaster’s Guide to Long-Range Planning, which you […]
Three Things We Learned in Our Orphan Drugs Webinar
Our recent orphan drugs webinar provided a wealth of insights into the current state and future of the orphan drug market. It was based on our annual report (which is available here) and if you missed it, I recommend taking the time to watch the on-demand version. Our panel included the report’s author, Melanie Senior […]
The Pharma Files: What Have you Missed?
As you probably know, Evaluate has an incredibly rich and comprehensive set of data and insight about the pharma market. This means we’re able to produce some really valuable reports, webinars and articles that provide insight around the most exciting areas of the industry. And we create rather a lot of them, which can make […]
Is it Time to Rethink Orphan Drugs?
If you follow Evaluate’s regular white papers and blogs, you may be familiar with our annual report that investigates the state of the orphan drug market. I’ve been involved in analyzing that data for the past three years, and have just finished the process for this year’s report which will be published soon. One of […]
How Pharma Professionals Rate Our Forecasting Training
Formal training is essential for stakeholder teams looking to enhance their forecasting expertise. By deepening their understanding of fundamental principles, methodologies, and process steps, teams can approach forecasting with greater confidence and ensure they are applying best practices effectively. However, learning should not be a passive process. We believe self-assessment is a powerful tool for […]
Three Things we Learned in our Long-Range Planning Webinar
How’s your long-range planning going? If you’re tasked with the forecasting processes for a pharma or biotech company, you may be in the midst of this annual cycle at the moment. Long-range planning (or LRP as the cool forecasters call it) provides a really important guide to company performance over five to 10 years. Like […]
Overcoming Challenges in Long-Range Planning Forecasting
Long-Range Planning (LRP) is no easy feat. As someone who has worked extensively in this area, I’ve seen firsthand the complexities and challenges that professionals face – whether it’s managing diverse portfolios, navigating cross-functional dynamics, or working with tools that just don’t fit the bill. That’s why I’m thrilled to be taking part in this […]
Biopharma Reading List: The Evaluate Top 10 of 2024
Obesity. The Inflation Reduction Act. Orphan Drugs. CDMOs. Successful forecasting techniques. We’ve covered all this and more in our biopharma reports, webinars and analysis throughout 2024. As I’ve had the pleasure of working with our experts to create all this content, I thought year-end was a splendid opportunity to share the most-read pieces of the […]
Three Things we Learned in our Launch Excellence Webinar
Picture the scene. You’ve got a new, hugely promising new drug in the pipeline and all the clinical signs are looking good. Which means you have to start focusing on your launch strategy to ensure commercial success. You need to refine your list of potential opportunities and threats, and develop forecasts that will ensure the […]
Mastering the Move from Phase III to Launch
The journey from Phase III clinical trials to a successful product launch is both exciting and challenging. It’s a crucial stage that sets the foundation for how a new product will perform in the market. But with resources often already allocated to established brands, and the need for precise forecasting and planning, launching a new […]
